Frequently Asked Questions
Common Questions About Using ICD-10 Code D75.822 for Immune-mediated heparin-induced thrombocytopenia
What are the common symptoms of immune-mediated heparin-induced thrombocytopenia?
Common symptoms include a decrease in platelet count, unusual bruising, bleeding, and signs of thrombosis such as swelling or pain in the limbs.
How is immune-mediated heparin-induced thrombocytopenia diagnosed?
Diagnosis is typically made through clinical evaluation, platelet count monitoring, and laboratory tests for antibodies against platelet factor 4.
What treatment options are available for immune-mediated heparin-induced thrombocytopenia?
Treatment involves discontinuing heparin, using alternative anticoagulants, and monitoring for thrombotic complications.
When should ICD-10 Code D75.822 be used?
This code should be used when documenting cases of immune-mediated heparin-induced thrombocytopenia in patients with a history of heparin exposure and thrombocytopenia.
